Second Nature
Behaviour-based weight loss app
- 101-200 employees
- B2C
- Lifestyle
- Fitness
- Nutrition
- Mobile
- Wellbeing
- Shepherd's Bush, London, UK
Jump to section
Company mission
To make healthy living second nature.
Our take
Second Nature is a digital behavioural change programme designed to help people with type 2 diabetes manage their illness by living more active lives, helping to prevent or reduce their symptoms. The company works closely with in-house dietitians, psychologists, and behavioural change specialists to tackle this pressing issue and create the programme.
The company produces a fitness wristband that monitors the user's steps, sleep, heart rate, and weighing scales to track their progress. The products use a small SIM card and Bluetooth to automatically sync with the user's phone, which provides real-time updates on their condition over a six-week period.
Impressively, Second Nature is the first digital lifestyle change programme to be used by the NHS. The company has also teamed up with Dr. Rupy Aujla from The Doctor’s Kitchen, who is an NHS GP and Sunday Times bestselling author who believes that food can have powerful medicinal effects. With this kind of momentum, the company is sure to see even more success in the future.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Competitive salary
- Share options in a growing and profitable health-tech company
- 25 days holiday plus national holidays
- Salary Sacrifice and Cycle to Work schemes
- Hybrid working: 2 days/week in our London office
- Remote flexibility: work from abroad up to 4 weeks at a time (within 2-hour UK time zone)
- £200/year professional development budget, plus extra for role-specific training
- Quarterly in-person socials and company meet-ups
- A friendly, mission-driven team where your work really matters
Funding (last 2 of 7 rounds)
Apr 2020
$10.6m
SERIES A
Dec 2019
$10.6m
SERIES A
Total funding: $24.9m
This company has top investors
Leadership
Chris Edson
(Co-Founder & CEO)Studied Engineering and Materials Science at the University of Oxford. Previously worked as a Senior Consultant at Deloitte.
Mike Gibbs
(Co-Founder & COO)Studied Pharmacology at the University of Cambridge. Previously worked as a Senior Consultant at Deloitte.